Skip Navigation


NDT Advance Access originally published online on July 16, 2008
Nephrology Dialysis Transplantation 2008 23(12):3895-3900; doi:10.1093/ndt/gfn383
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/12/3895    most recent
gfn383v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cheng, L.-T.
Right arrow Articles by Wang, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, L.-T.
Right arrow Articles by Wang, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Stepwise increase in the prevalence of isolated systolic hypertension with the stages of chronic kidney disease

Li-Tao Cheng1, Yan-Li Gao1,2, Yue Gu1, Li Zhang1, Shu-Hong Bi1, Wen Tang1 and Tao Wang1

1 Division of Nephrology, Peking University Third Hospital, Beijing 2 Division of Cardiology, the Second Clinical College of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China

Correspondence and offprint requests to: Li-Tao Cheng, Division of Nephrology, Peking University Third Hospital, 49 North Garden Rd, Haidian District, Beijing 100083, China. Tel: +86-10-62017691 Ext. 3296; Fax: +86-10-62017691 Ext. -2517; E-mail: ltcheng{at}bjmu.edu.cn



  Abstract

Background. Hypertension is common in patients with chronic kidney disease (CKD), and isolated systolic hypertension (ISH) accounts for most patients with inadequate blood pressure (BP) control. However, it remains unclear whether the prevalence of ISH would increase with the advancement of CKD.

Methods. CKD patients of stages 3, 4 and 5 were recruited (n = 324). Based on office systolic BP (SBP) and diastolic BP (DBP), they were classified into any of the four hypertensive subtypes: normotension (SBP/DBP <140/90 mmHg), isolated diastolic hypertension (IDH, SBP <140 mmHg and DBP ≥90 mmHg), ISH (SBP ≥140 mmHg and DBP <90 mmHg) and systolic–diastolic hypertension (SDH, SBP/DBP ≥140/90 mmHg).

Results. The control rate was 45.7% at stage 3, which decreased with the advancement of CKD (control rate was 51.9%, 40.4% and 38.6% in stage 3, 4 and 5, respectively; P < 0.05). The prevalence of IDH changed from 5.0% to 5.3% and 0% from stage 3 to 4 and 5, while there was no significant change in the prevalence of SDH (15.0%, 14.9% and 15.7% at stage 3, 4 and 5, respectively). There was a stepwise increase in the prevalence of ISH with the stages of CKD (it was 28.1%, 39.4% and 45.7% in stage 3, 4 and 5, respectively). Logistic regression showed that age and CKD stages [compared with stage 3, stage 4 and 5 had 2.57 (95% CI 1.04–6.33) and 3.68 (95% CI 1.09–12.47) folds higher risk to develop ISH, respectively] were independent predictors of ISH.

Conclusion. The prevalence of ISH increased correspondingly with advanced stages of CKD, which may partially contribute to the increased cardiovascular mortality during the progress of CKD.

Keywords: chronic kidney disease; hypertension; isolated diastolic hypertension; isolated systolic hypertension; systolic–diastolic hypertension

Received for publication: 27. 3.08
Accepted in revised form: 16. 6.08


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
R. Agarwal and R. P. Light
GFR, proteinuria and circadian blood pressure
Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2400 - 2406.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.